Tumor Marker Tests.

Slides:

Advertisements

Similar presentations

Dr. Amal S. Ahmed Ass Prof.Clinical Pathology Suez Canal University

Advertisements

Diagnostic tests include: Physical examination Laboratory tests Imaging Endoscopic examination Biopsy Surgery Molecular testing How is cancer diagnosed?

Introduction The incidence of prostate cancer in Asians is lower compared to the Westerners in men with PSA

TUMOR MARKERS Prof. Dr.Yıldız DİNÇER.

Preventing Cancer with Healthy Life Styles Li-Fen L. Chang, M.D., Ph.D. Radiation Oncology SOMC Cancer Center.

Tumor Markers Useful tool or part of the problem? Dr. Grant MacLean.

Antineoplastics  W hat is Cancer ? Cancer is a disorder of cell division (leading cause of death).  C C ancers most commonly occur in: breast (♀) -

Doç.Dr. Jale Çoban Klinik Biyokimya Uzmanı

Cancer Dr. Raid Jastania. Cancer In the US: 1.3 million new cancer cases in 2002 >500,000 death of cancer Increase cancer death in men due to lung cancer.

Cancer Genes, Environment and Behaviour Program Professor Bruce Armstrong School of Public Health.

Chapter 12 Liver, Gallbladder, and Pancreas Diseases and Disorders

Tumor Markers Dr/ Ehsan Mohamed Rizk. A substance that is present in or produced by a tumor or by the host in response to tumor’s presence. An ideal tumor.

Medullary Thyroid Cancer By : Michelle bacon Definition  Also called (MTC) - is a form of thyroid carcinoma which originates from the parafollicular.

Plasma proteins Lecture 3.

Eleni Galani Medical Oncologist

Tumor Markers: Clinical Usefulness

Tumor Markers By: dr. hassan el-banna.

Biomarkers Andrew McNaught BME. What is a biomarker? Gives us the ability to analyze organ function, diagnose diseases in a non-invasive way. Biomarkers.

Biomarkers: challenges or pitfalls for patients Liesbeth Lemmens Digestive oncology University hospitals Leuven.

بسم الله الرحمن الرحيم.

Towards Earlier Cancer Diagnosis Hamish Whitaker GP Tutor Guildford.

EKUSILENI CLINICAL LABORATORY

Tumor Markers Lecture two By Dr. Reem Sallam. Objectives  To briefly enumerate the most commonly used methods to test for tumor markers  To describe.

Cancer By: Erionne. What is Cancer Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you.

Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.

Principles of Surgical Oncology Salah R. Elfaqih.

PANCREATIC CANCER.

OF COLOREATAL CANCER USING SEROLOGIC TUMOR MARKERS DIAGNOSIS & MANAGEMENT.

Tumor markers Present; by Dr. Andalib Isfahan Medical School

Biochemical markers in disease diagnosis

Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Tumormarkers.

وما أوتيتم من العلم إلا قليلاً. Prepared by: Abdo A Elfiky.

Principles of Surgical Oncology Done by : 428 surgery team surgery team.

6/2/2016Naglaa Alhusseini1 TUMOR MARKERS Naglaa Fathy Alhusseini Ass.Prof. of Biochemistry and Molecular Biology

Tumor Markers American cancer society British Journal of Cancer By B.Heidari.

Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.

Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Chapter 19 Tumor Markers Zou Xiong. DEFINITIONS-1 Tumor markers originally were defined as substances that can be measured quantitatively by immunochemical.

Lecture 11 Immunology Tumor immunology Dr: Dalia Galal.

Principles of Surgical Oncology

Biochemical markers for diagnosis and follow up of disease

Cancer “whiteboard” presentation ●Name of cancer (what type), where can it occur? ●Function of body part that it affects ●Causes (genetic, environmental…)?

By: Kaylee Copas. What is cancer? Cancer is the uncontrolled growth of abnormal cells in the body. Cancerous cells are also called malignant cells.

NEOPLASIA -4 Dr Samal Nauhria Viral and Bacterial Oncogenesis HTLV-1 : a retrovirus, endemic in Japan, the Caribbean, and parts of.

Introduction and overview of CA19-9 CA19-9 is a tumour associated antigen found in the blood serum. CA 19-9 is also known as the Sialylated Lewis-antigen.

Prof. A. Angeloni.  Biological substances synthesized and released by cancer cells themselves or  Produced by the host in response to the presence of.

Unit 6: Tumor markers. Introduction… Cancer is the second leading cause of death in North America, accounting for > 2.7 million deaths annually Although.

Common pitfall in Oncology Luangyot Thongthieang, MD MEDICAL ONCOLOGY UNIT INTERNAL MEDICINE, KHONKAEN HOSPITAL.

Prostate Cancer. Basic facts The prostate is a gland the size of a walnut it sits at the neck of the bladder Only men have a prostate gland! Prostate.

Qualified Patient Criteria Combinations (Female and Male) Personal History of (any one of the below): Breast or Ovarian cancer (any age) Prostate or Pancreatic.

Tumor markers 1111.

SURGICAL ONCOLOGY AND TUMOR MARKERS

Ovarian tumor markers Associate Professor Fariba Behnamfar

Male Reproductive System

– Color Index: Important. Extra Information. Doctors slides.

US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death

Principles of Surgical Oncology

biochemical markers for diagnosis and follow up of diseases

Biochemical markers for diagnosis of diseases and follow up

Presented By: Sally Saad Mandour Esawy

PROSTATE CANCER.

ד"ר שרית בר ששת בי"ח בילינסון

Neoplasia (6 of 6) Ali Al Khader, M.D. Faculty of Medicine

Prostate Cancer Awareness

Estimated current cancer incidence

Biochemical markers for diagnosis of diseases and follow up

Presentation transcript:

Tumor Marker Tests

Tumor Markers Substances produced by cancer Substances produced by other cells in response to cancer Found in blood, urine, stool, bodily fluids More than 20 tumor markers

AFP Alpha fetoprotein liver and germ cell tumors diagnose liver cancer and follow response to treatment, assess stage and prognosis follow response of treatment of germ cell cancers

B2M Beta 2 Microglobulin Myeloma, leukemia, some lymphomas determine prognosis and response to treatment CA19-9 follow treatment response in pancreatic, gallbladder, bile duct, and gastric cancer

Calcitonin Medullary thyroid cancer aid in diagnosis, treatment response CA 125 Ovarian cancer

PSA prostate specific antigen aid in diagnosis, treatment response, assess recurrence screen men for cancer BEFORE symptoms present themselves elevated levels may or may not indicate cancer